BUAD Results for Clinical Trial on Vioxx

BUAD Results for Clinical Trial on Vioxx - Similarly, 33.7%...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Results for Clinical Trial on Vioxx Effect 0-6mo 6-12mo 12-18mo Pain reduced V 38.5% 65.3% 90.4% Pain reduced N 3.8% 6.8% 7.8% Reduced Colon Polyps V 3.8% 7.5% 17.3% Reduced Colon Polyps N 1.7% 1.9% 2% Inc. Range of motion V 33.7% 46.9% 60.3% Inc. range of motion N 4.4% 5.2% 6.8% Cardiac Incidents V 0.15% 0.65% 1.5% Cardiac incidents N 0.12% 0.54% 0.77% Intestinal bleeding V 0.62% 1.3% 1.5% Intestinal bleeding N 0.42% 0.65% 0.92% Stomach Ulcers V 0.27% 0.69% 0.85% Stomach ulcers N 0.04% 0.35% 0.62%
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
The results of the clinical trial appear to indicate that Vioxx has a significant effect in terms of pain reduction for patients taking Vioxx versus patients not taking Vioxx. 38.5% of participants taking Vioxx experienced pain reduction in the first six months of the study, compared to only 3.8% of those in the control group. This figure increased to 90.4% of participants after taking Vioxx for twelve to eighteen months, while the number of participants in the control group experiencing pain reduction remained relatively low at 7.8%.
Background image of page 2
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Similarly, 33.7% of Vioxx users reported increased range of motion in the first six months, compared to 4.4% of patients in the control group. This figure also increased to 60.3% of participants after they had been taking Vioxx for twelve to eighteen months, while only 6.8% of the control group reported increased range of motion. The study also indicates that Vioxx can have significant benefits in the reduction of colon polyps, and the benefit appears to increase the longer that Vioxx is taken. 3.8% of Vioxx participants report reduced colon polyps in the first six months; 7.5% after six to twelve months, and 17.3% of patients taking Vioxx for twelve to eighteen months report reduced colon polyps. When this data is compared to that of the control group, which remains fairly constant at around 2% of participants, the potential benefit of Vioxx for reducing colon polyps is clear....
View Full Document

Page1 / 2

BUAD Results for Clinical Trial on Vioxx - Similarly, 33.7%...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online